Force Featured Research Search Results

Using a Mobile Health App to Improve Quality of Life in Black Men with Prostate Cancer

https://www.facingourrisk.org/research-clinical-trials/study/411 /using-a-mobile-health-app-to-improve-quality-of-life-in-black-men-with-prostate-cancer

Clinicaltrials.gov identifier:
NCT06651359 (https://clinicaltrials.gov/show/NCT06651359)

Quality of Life
Quality of life study for Black men with prostate cancer

Study of a New Oral Medication, Daraxonrasib After Surgery to Help Prevent Pancreatic Cancer from Returning

https://www.facingourrisk.org/research-clinical-trials/study/378 /study-of-a-new-oral-medication-daraxonrasib-after-surgery-to-help-prevent-pancreatic-cancer-from-returning

Clinicaltrials.gov identifier:
NCT07252232 (https://clinicaltrials.gov/show/NCT07252232)

Treatment
Phase 3 treatment trial for pancreatic cancer that was removed by surgery

ENGAGE: Surveys to Assess Decision-Making on Genetic Counseling and Testing for Lynch Syndrome

https://www.facingourrisk.org/research-clinical-trials/study/416 /engage-surveys-to-assess-decision-making-on-genetic-counseling-and-testing-for-lynch-syndrome

Clinicaltrials.gov identifier:
NCT07106359 (https://clinicaltrials.gov/show/NCT07106359)

Surveys, Registries, Interviews
Clinical trial for untested individuals at risk for Lynch syndrome

Share Your Child's Genetic Diagnostic Journey

https://www.facingourrisk.org/research-clinical-trials/study/417 /share-your-childs-genetic-diagnostic-journey

Surveys, Registries, Interviews
Interview with Latino/a parents about their child's genetic care

Comparing Two Vaccine Treatments With Immunotherapy for Pancreatic Cancer Before and After Surgery

https://www.facingourrisk.org/research-clinical-trials/study/386 /comparing-two-vaccine-treatments-with-immunotherapy-for-pancreatic-cancer-before-and-after-surgery

Clinicaltrials.gov identifier:
NCT06782932 (https://clinicaltrials.gov/show/NCT06782932)

Treatment
Treatment study for newly diagnosed pancreatic cancer that can be removed with surgery and who have not yet received treatment

Studying the Impact of Cancer-Related Financial Challenges on Couples’ Health

https://www.facingourrisk.org/research-clinical-trials/study/399 /studying-the-impact-of-cancer-related-financial-challenges-on-couples-health

Surveys, Registries, Interviews
Survey for people who are receiving or have received cancer treatment and their partner

Comparing an Investigational Targeted Drug AZD5335 to Standard Treatments in People With Platinum‑Resistant Ovarian Cancer (TREVI‑OC‑01)

https://www.facingourrisk.org/research-clinical-trials/study/371 /comparing-an-investigational-targeted-drug-azd5335-to-standard-treatments-in-people-with-platinumresistant-ovarian-cancer-trevioc01

Clinicaltrials.gov identifier:
NCT07218809 (https://clinicaltrials.gov/show/NCT07218809)

Treatment
Treatment study for platinum-resistant ovarian cancer

Using a Blood Test to Detect Early Cancer Recurrence After Treatment (ORACLE)

https://www.facingourrisk.org/research-clinical-trials/study/372 /using-a-blood-test-to-detect-early-cancer-recurrence-after-treatment-oracle

Clinicaltrials.gov identifier:
NCT05059444 (https://clinicaltrials.gov/show/NCT05059444)

Treatment
Post-treatment study to monitor for recurrence

A Study for Women Having Revision Breast Implant Surgery

https://www.facingourrisk.org/research-clinical-trials/study/402 /a-study-for-women-having-revision-breast-implant-surgery

Clinicaltrials.gov identifier:
NCT05945329 (https://clinicaltrials.gov/show/NCT05945329)

Prevention
An interventional study for women undergoing revision breast implant surgery

SCREEN-CUP: Menstrual Cup Screening for Endometrial Cancer in Lynch Syndrome

https://www.facingourrisk.org/research-clinical-trials/study/398 /screen-cup-menstrual-cup-screening-for-endometrial-cancer-in-lynch-syndrome

Clinicaltrials.gov identifier:
NCT07220239 (https://clinicaltrials.gov/show/NCT07220239)

Prevention
Screening study for endometrial cancer

An Early Detection and Prevention Study for People with an Increased Risk of Cancer (InAdvance)

https://www.facingourrisk.org/research-clinical-trials/study/385 /an-early-detection-and-prevention-study-for-people-with-an-increased-risk-of-cancer-inadvance

Clinicaltrials.gov identifier:
NCT05463796 (https://clinicaltrials.gov/show/NCT05463796)

Prevention
Study for people at risk of cancer, including previvors, survivors and family members

Genetic Testing for Cancer Risk for Black Families in Texas

https://www.facingourrisk.org/research-clinical-trials/study/396 /genetic-testing-for-cancer-risk-for-black-families-in-texas

Clinicaltrials.gov identifier:
NCT05694559 (https://clinicaltrials.gov/show/NCT05694559)

Prevention
Study to improve genetic counseling and testing to Black families in Texas

Comparing an Experimental Drug Puxi-Sam to Standard Chemotherapy for Metastatic Endometrial Cancer (Bluestar‑Endometrial01)

https://www.facingourrisk.org/research-clinical-trials/study/370 /comparing-an-experimental-drug-puxi-sam-with-standard-chemotherapy-for-metastatic-endometrial-cancer-bluestarendometrial01

Clinicaltrials.gov identifier:
NCT07044336 (https://clinicaltrials.gov/show/NCT07044336)

Treatment
Phase 3 treatment study for metastatic endometrial cancer

Treating Advanced Solid Tumors with Targeted Therapies Called RAS(ON) Inhibitors Combined With the Targeted Immunotherapy Ivonescimab

https://www.facingourrisk.org/research-clinical-trials/study/408 /treating-advanced-solid-tumors-with-the-rason-inhibitor-daraxonrasib-combined-with-a-targeted-immunotherapy-ivonescimab

Clinicaltrials.gov identifier:
NCT07397338 (https://clinicaltrials.gov/show/NCT07397338)

Treatment
Treatment study for solid tumors with a RAS mutation

Study of a New Drug, Sacituzumab Tirumotecan, Given Alone or in Combination with an Immunotherapy for Metastatic, Triple-Negative Breast Cancer (TroFuse-011)

https://www.facingourrisk.org/research-clinical-trials/study/359 /study-of-a-new-drug-sacituzumab-tirumotecan-given-alone-or-in-combination-with-an-immunotherapy-for-people-with-triple-negative-breast-cancer

Clinicaltrials.gov identifier:
NCT06841354 (https://clinicaltrials.gov/show/NCT06841354)

Treatment
Phase 3 treatment study for people with metastatic, triple-negative breast cancer

The EASE Study: Helping People with Advanced Cancer Cope with Fear of Cancer Progression

https://www.facingourrisk.org/research-clinical-trials/study/413 /the-ease-study-helping-people-with-advanced-cancer-cope-with-fear-of-cancer-progression

Clinicaltrials.gov identifier:
NCT07636200 (https://clinicaltrials.gov/show/NCT07636200)

Quality of Life
Quality of life study for people with advanced cancer experiencing anxiety

Perceptions of Gastric Cancer Risk and Attitudes Toward Endoscopic Surveillance in People with CDH1 or CTNNA1 Mutations

https://www.facingourrisk.org/research-clinical-trials/study/390 /perceptions-of-gastric-cancer-risk-and-attitudes-toward-endoscopic-surveillance-in-people-with-cdh1-or-ctnna1-mutations

Surveys, Registries, Interviews
Online survey about gastric cancer risk and medical decision-making for people with an inherited CDH1 or CTNNA1 pathogenic variant

Treating Advanced Solid Tumors with a KRAS G12C Mutation Using Targeted Therapies Called RAS(ON) Inhibitors

https://www.facingourrisk.org/research-clinical-trials/study/409 /treating-advanced-solid-tumors-with-a-kras-g12c-mutation-using-targeted-therapies-called-rason-inhibitors

Clinicaltrials.gov identifier:
NCT06128551 (https://clinicaltrials.gov/show/NCT06128551)

Treatment
Treatment study for advanced colorectal, pancreatic or lung cancer with a KRAS G12C mutation

FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.

Featured Studies Results